As of December 2024 Allergy Therapeutics has a market cap of €0.38 Billion. This makes Allergy Therapeutics the world's 7131th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.